logo
Search for
Tests or Packages
Call us at 1800-266-5533
LifeCell Diagnostics Achieves 100% CAP NGSST-A Results for the Fourth Consecutive Year
Health Check

LifeCell Diagnostics Achieves 100% CAP NGSST-A Results for the Fourth Consecutive Year

Written By Preeti Singh - November 13, 2026
Modified On -November 13, 2026
Read Time - 4 Mins

Precision is not achieved by chance. It comes from getting the details right, every single time.

LifeCell Diagnostics has proven this belief through its work. For the fourth consecutive time, its Oncogenomics Department has achieved 100% sensitivity, 100% specificity and 100% correct variant calls in the College of American Pathologists (CAP) NGS Solid Tumor (NGSST-A) 2026 proficiency evaluation.

This milestone reflects the team's continued commitment to accuracy and quality in cancer genomic testing.

What Is CAP NGSST-A Evaluation?

Next-Generation Sequencing (NGS) helps laboratories identify genetic changes linked to cancer by analysing multiple genes at the same time.

To assess the accuracy of this testing, the College of American Pathologists (CAP) conducts independent proficiency evaluations.

Its NGS Solid Tumor (NGSST-A) programme evaluates how accurately laboratories identify genetic changes in solid tumours using NGS technology.

What Does LifeCell's 100% Result Mean?

In the CAP NGSST-A 2026 evaluation, LifeCell Diagnostics achieved 100% sensitivity, 100% specificity and 100% correct variant calls. This means the team correctly identified all expected positive genetic changes, reported no false calls and matched all assessed variant calls with the expected results.

The evaluation covered multiple cancer-associated markers, including EGFR, KRAS, BRAF, PIK3CA and others. 

Why Do These Results Matter?

People with the same form of cancer can have genetic differences in their tumours. And because of this it is important to identify such alterations accurately to help doctors:

  • Detect important changes early to understand the cancer better.
  • Make treatment decisions based on the patient's individual cancer profile rather than taking the same approach for everyone.

A Commitment to Accuracy

Getting 100% results once is a big achievement. Doing it four times in a row makes it even more special.

Behind this achievement is a team that puts care, skill and attention into every test. Their consistent efforts have helped LifeCell Diagnostics maintain this standard across four consecutive CAP evaluations.

A big congratulations to the entire Oncogenomics team: Dr. Phani M.N, Dr. Tina Bhardwaj and Dr. Mukin Kumar Sonai! This achievement is a reflection of your hard work and dedication. Keep setting new benchmarks in cancer genomic testing.

References

+

Need Help Choosing the Right Diagnostic Test? Get expert advice in minutes

+91

Related Products

Comment(s)

Are You Family Expecting A Baby?

I authorise LifeCell International Pvt.Ltd & its representatives to contact me with updates and notifications via Email/SMS/WhatsApp/Call. This will override DND/NDNC.

start